← Back to Search

Low-Gain Hearing Aids

Receiver in the canal (RIC) hearing aids for Tinnitus

N/A
Waitlist Available
Led By Tara Zaugg, AuD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
a score of 5 or greater on section A the Tinnitus and Hearing Survey during the telephone screening;
air conduction hearing thresholds of 25 dB HL or better from .25 kHz through 4 kHz bilaterally as measured at the first study visit;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the tinnitus functional index will be administered at baseline, 2-3 weeks after baseline, and 3 months after baseline
Awards & highlights

Study Summary

This study is evaluating whether hearing aids may help reduce tinnitus for individuals with normal hearing.

Eligible Conditions
  • Tinnitus
  • Hearing Aids
  • Normal Hearing

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the tinnitus functional index will be administered at baseline, 2-3 weeks after baseline, and 3 months after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and the tinnitus functional index will be administered at baseline, 2-3 weeks after baseline, and 3 months after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tinnitus Functional Index Change

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Hearing Aid StudyExperimental Treatment1 Intervention
Measure the reduction in tinnitus handicap when mild amplification through receiver-in-the-canal hearing aids is provided to adults with bothersome tinnitus and normal hearing thresholds.
Group II: VA Clinician InterviewsActive Control1 Intervention
Document the opinions, procedures, and rationale used clinically to make decisions regarding fitting mild amplification for tinnitus on Veterans with bothersome tinnitus and normal hearing thresholds. The data for this arm of the study will be collected via telephone interview.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Receiver in the canal (RIC) hearing aids
2020
N/A
~70

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,605 Previous Clinical Trials
3,305,629 Total Patients Enrolled
6 Trials studying Tinnitus
505 Patients Enrolled for Tinnitus
Tara Zaugg, AuDPrincipal InvestigatorVA Portland Health Care System, Portland, OR

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
Oregon
How old are they?
18 - 65
What site did they apply to?
VA Portland Health Care System, Portland, OR
What portion of applicants met pre-screening criteria?
Met criteria
~13 spots leftby Mar 2025